Blood Cancer Discovery Symposium | American Association for Cancer Research
The articles selected for this collection align with the topics presented at the Blood Cancer Discovery Symposium, showcasing the breadth and quality of
The articles selected for this collection align with the topics presented at the Blood Cancer Discovery Symposium, showcasing the breadth and quality of
The application of artificial intelligence methods to electronic patient records paves the way for large-scale analysis of multimodal data. Such population-wide data describing deep phenotypes…
Why the AQUILA trial is disappointing for patients and their loved ones
AbstractBACKGROUND AND AIMS. Over the last decade, treatment options for moderate-to-severe ulcerative colitis (UC) have expanded. However, comparative stu
Discussing the tradeoffs in public-health decisions might help us make better choices, write Dr. Christopher Worsham and Dr. Anupam Jena.
Treatment with adjuvant osimertinib for three years is the standard-of-care for resected stage IB-IIIA non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR)-mutations.…
Despite the scary headlines about genotoxicity, the answer is still probably no.
I hope that we can eventually take a deep breath, think, and return to how we managed things prior to the pandemic, except in cases…
Key Points. Air pollution exposure is common, and may increase risk of developing blood clots.Greater long-term exposure to air pollution (i.e., PM2.5, NOx
Charlie Marriage suffered a fatal seizure when he ran out of epilepsy medication across a weekend and failed to get a prescription despite several calls…
OpenAI’s o3 model scored at human level on a benchmark test for artificial general intelligence – far higher than any results before.